Diabetes Medications Find New Life as Weight-Loss Drugs

July 21, 2022

Novo Nordisk’s Saxenda (liraglutide) and Wegovy (semaglutide) are leading the way for a new crop of drugs that reduce appetite. But their cost-effectiveness is in question, and many payers are saying no to coverage — for now.

Needed: A Prevention Strategy To Stop Amputations Among Minority Populations Living With Complex Diabetes

June 24, 2022

Lower limb amputations are devastating for people living with diabetes, particularly for Black Americans facing poor access to comprehensive care. A coordinated, data-driven national prevention strategy is the only way to curb this growing epidemic for all at-risk populations.